Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 83

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 83
---
 whole company,
a disposition of the FYARRO business structured as an asset sale, and a disposition of the FYARRO business structured as a sale of Aadi Sub) and related considerations, including, among others: (i) the timing of returning cash to Aadi’s
stockholders; (ii) for transaction structures other than a sale of the whole company, the potential of increasing the bid amount for FYARRO on the basis of certain liabilities not transferring to the bidder; and (iii) for transaction
structures other than a sale of the whole company, the additional flexibility afforded to Aadi’s board of directors in evaluating Aadi’s strategic options to create long-term stockholder value by remaining as a public company, including
the potential in-license of new assets. Aadi’s board of directors also approved advancing Bidder E and Kaken into confirmatory due diligence based on the strength of their respective proposals.

On October 25, 2024, representatives of Aadi, Wilson Sonsini, BMS’s legal counsel, Bidder B and Bidder B’s legal counsel met via
videoconference to discuss certain intellectual property due diligence matters.

On October 28, 2024, at the direction of Aadi, representatives of
Leerink Partners sent a draft merger agreement to representatives of Nomura to share with Kaken (in light of Kaken’s initial proposal set forth in the Kaken October 17 Proposal, which contemplated a sale of the whole company).

On November 1, 2024, representatives of Leerink Partners and Nomura met via videoconference to further discuss the Kaken October 17 Proposal, the
draft merger agreement, and related issues.

On November 5, 2024, at a virtual meeting organized by representatives of Leerink Partners,
representatives of Aadi’s management team presented to representatives of Kaken’s management team and Nomura regarding the FYARRO business and related matters.

Beginning on November 6, 2024, representatives of Aadi’s management team, Kaken Parent’s management team, Leerink Partners, Nomura, Wilson
Sonsini and McDermott Will & Emery LLP (“McDermott”), outside legal counsel to Kaken Parent, held a number of meetings via videoconference to discuss various due diligence matters, including legal, finance and accounting, and
intellectual property.

On November 7, 2024, representatives of Bidder B sent a proposed exclusivity agreement to representatives of Leerink
Partners, under